These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7264760)

  • 1. Technetium radiopharmaceuticals: chemical characterization and tissue distribution of Tc-glucoheptonate using Tc-99m and carrier Tc-99.
    de Kieviet W
    J Nucl Med; 1981 Aug; 22(8):703-9. PubMed ID: 7264760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of renal concentration of technetium-99m glucoheptonate.
    Lee HB; Blaufox MD
    J Nucl Med; 1985 Nov; 26(11):1308-13. PubMed ID: 2997418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal imaging: comparison of technetium Tc 99m glucoheptonate with conventional arteriography.
    Klein FA; Texter JH; Zelenak J; Hietala SO
    South Med J; 1981 Feb; 74(2):187-90. PubMed ID: 7466437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial evaluation of new 99mTc(CO)3 renal imaging agents having carboxyl-rich thioether ligands and chemical characterization of ReCO3 analogues.
    He H; Lipowska M; Christoforou AM; Marzilli LG; Taylor AT
    Nucl Med Biol; 2007 Aug; 34(6):709-16. PubMed ID: 17707812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of technetium-99m glucoheptonate and gallium-67 citrate thoracic imaging in detection of mediastinal and hilar involvement in primary lung cancer.
    Taillefer R; Beauchamp G; Léveillé J
    Clin Nucl Med; 1986 Jan; 11(1):15-9. PubMed ID: 3455906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexes of technetium with hydroxycarboxylic acids: gluconic, glucoheptonic, tartaric, and citric.
    Russell CD; Speiser AG
    J Nucl Med; 1980 Nov; 21(11):1086-90. PubMed ID: 7431109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biliary propensities of technetium-99m glucoheptonate.
    Noronha OP
    J Nucl Med; 1986 Oct; 27(10):1647-8. PubMed ID: 3760993
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrolytic complexing of glucoheptonate and technetium-99m.
    Chi SL; Hoag SG; Yanchick VA
    J Nucl Med; 1978 May; 19(5):520-4. PubMed ID: 641575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of obtaining renal images following brain scintigraphy with technetium-99m glucoheptonate.
    Moreno AJ; Rodriguez AA; Spicer MJ; Jackson RE; Byrd BF; Turnbull GL
    Clin Nucl Med; 1986 Aug; 11(8):560-3. PubMed ID: 3742911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suprarenal abscess in the neonate. Technetium-99m glucoheptonate imaging.
    Wells RG; Sty JR; Hodgson NB
    Clin Nucl Med; 1986 Jan; 11(1):32-4. PubMed ID: 3510789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of technetium-99m glucoheptonate utilizing formamidine sulfinic acid.
    Scott JR; Garrett GL; Lentle BC
    Int J Nucl Med Biol; 1980; 7(1):71-3. PubMed ID: 7358471
    [No Abstract]   [Full Text] [Related]  

  • 12. Uptake of Tc-99m glucoheptonate in cervical lymph node metastases from large-cell bronchogenic carcinoma.
    Sauerland BA; Rosen PR; Weiland FL; Lasher JC; Myers DL; Hale AS
    Clin Nucl Med; 1983 Jan; 8(1):31-3. PubMed ID: 6339148
    [No Abstract]   [Full Text] [Related]  

  • 13. Immediate and delayed TC-99M glucoheptonate brain images.
    Boade WA
    S D J Med; 1981 Jun; 34(6):19-20. PubMed ID: 6943675
    [No Abstract]   [Full Text] [Related]  

  • 14. Biliary excretion of Tc-99m-glucoheptonate in poor renal function.
    Wilson MA; Pastakia B
    Clin Nucl Med; 1980 Oct; 5(10):448-9. PubMed ID: 6996887
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucoheptonate measurement of differential renal function.
    Powers TA; Stone WJ; Witt WS; Killion LT; Patton JA
    J Urol; 1984 Jul; 132(1):175-8. PubMed ID: 6726952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early and delayed Tc-99m glucoheptonate brain scintigraphy: are routine early images indicated?
    Tanasescu DE; Wolfstein RS; Brachman MB; Waxman AD
    J Nucl Med; 1979 Apr; 20(4):287-90. PubMed ID: 536804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor accumulation of technetium-99m glucoheptonate in sarcoidosis and other diffuse infiltrative lung diseases as compared with gallium-67 citrate.
    Vorne M; Sahlström K; Alanko K
    Clin Nucl Med; 1988 Feb; 13(2):107-9. PubMed ID: 3162408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium-99m glucoheptonate in brain-tumor detection: an important advance in radiotracer techniques.
    Léveillé J; Pison C; Karakand Y; Lemieux R; Vallières BJ
    J Nucl Med; 1977 Oct; 18(10):957-61. PubMed ID: 903478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of apoptosis with 99mTc-glucoheptonate.
    Kocagozoglu G; Lambrecht FY; Gunduz C; Yucebaş M; Tabar EB; Ozgur A; Balci T
    Appl Radiat Isot; 2011 Jul; 69(7):955-9. PubMed ID: 21459007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m glucoheptonate as a scanning agent in hepatocellular carcinoma.
    Esser JD; Kew MC; Tobias M; Winterton R; Savitch I; Levin J
    Clin Nucl Med; 1985 Aug; 10(8):586-8. PubMed ID: 2994936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.